HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Yue Lai Selected Research

Lipids

9/2017CCAAT/enhancer-binding protein delta promotes intracellular lipid accumulation in M1 macrophages of vascular lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Yue Lai Research Topics

Disease

13Neoplasms (Cancer)
12/2023 - 11/2015
7Rectal Neoplasms (Rectal Cancer)
03/2023 - 01/2021
5Carcinogenesis
12/2023 - 01/2022
5Carcinoma (Carcinomatosis)
06/2023 - 01/2021
4Cholangiocarcinoma
12/2023 - 01/2023
3Neoplasm Metastasis (Metastasis)
01/2023 - 09/2021
2Nasopharyngeal Carcinoma
01/2022 - 01/2022
2Liver Neoplasms (Liver Cancer)
01/2020 - 11/2015
1Colorectal Neoplasms (Colorectal Cancer)
11/2022
1Hypersensitivity (Allergy)
01/2022
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2021
1Leukemia
01/2021
1Inflammation (Inflammations)
09/2017
1Atherosclerotic Plaque (Atheroma)
09/2017
1Cardiovascular Diseases (Cardiovascular Disease)
09/2017
1Hepatocellular Carcinoma (Hepatoma)
02/2017

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2022
4CCAAT-Enhancer-Binding Protein-deltaIBA
01/2020 - 11/2015
3Indicators and Reagents (Reagents)IBA
12/2023 - 07/2021
2Cartilage Oligomeric Matrix ProteinIBA
10/2023 - 01/2022
2Proteins (Proteins, Gene)FDA Link
06/2023 - 09/2017
2Oxidoreductases (Dehydrogenase)IBA
01/2022 - 01/2021
2Metformin (Glucophage)FDA LinkGeneric
01/2020 - 02/2017
2Transcription Factors (Transcription Factor)IBA
09/2017 - 02/2017
1EnzymesIBA
12/2023
1Ubiquitin-Conjugating EnzymesIBA
12/2023
1Laminin (Merosin)IBA
12/2023
1Heparin (Liquaemin)FDA LinkGeneric
12/2023
1dihydropyrimidinaseIBA
06/2023
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2023
1NucleotidesIBA
11/2022
1ForminsIBA
01/2022
1Immunoglobulin E (IgE)IBA
01/2022
1MetallothioneinIBA
01/2022
1MetalsIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1CateninsIBA
01/2022
1Mucin-2IBA
07/2021
1Cathepsin EIBA
07/2021
1Peptides (Polypeptides)IBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1ParaffinIBA
01/2021
1GemcitabineFDA Link
01/2021
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2021
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
01/2021
1Pyruvic Acid (Pyruvate)IBA
01/2021
1LeptinIBA
01/2021
1aristolochic acid I (aristolochic acid)IBA
01/2021
1APOBEC-1 DeaminaseIBA
01/2021
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
01/2021
1AMP-Activated Protein KinasesIBA
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2020
1LipidsIBA
09/2017
1Apolipoproteins E (ApoE)IBA
09/2017
1DecitabineFDA Link
11/2015

Therapy/Procedure

7Chemoradiotherapy
03/2023 - 01/2021
2Radiotherapy
01/2023 - 01/2022
2Drug Therapy (Chemotherapy)
01/2022 - 09/2021
1Proctectomy
01/2021